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Introduction 
Angiosarcomas are malignant neoplasms derived 
from endothelial cells that historically carry a very 
poor prognosis [1]. They are rare aggressive tumors, 
accounting for around 2% of all soft tissue sarcomas. 
Cutaneous angiosarcomas, the most common type, 
comprise about 60% of all angiosarcomas [2]. 
Although the most common form of cutaneous 
angiosarcoma is the spontaneous/idiopathic form 
typically arising in the head and neck [3], 
angiosarcomas have also been associated with 
chronic lymphedema, as well as a history of radiation 
treatment [1, 3]. Herein, we present a patient with 
cutaneous angiosarcoma arising in the lower 
extremity of an elderly patient. 
 
Case Synopsis 
A 71-year-old man presented with discoloration of 
his left distal lower extremity for the past two years. 
He denied any itching, tenderness, or bleeding. His 
past medical history included diabetes, 
hypertension, and non-melanoma skin cancer. 
Medications included aspirin 325mg, atenolol 50mg, 
glyburide 5mg, hydrochlorothiazide 25mg, 
ibuprofen 600mg, lovastatin 40mg, nifedipine 30mg, 
and prazosin 5mg. He denied any allergies. On a 
previous visit to a dermatology office, he was initially 
diagnosed with necrobiosis lipoidica. He returned 
approximately seven months later with an eruption 
of black nodules within the discoloration that he 
reported appeared after bumping his shin a few 
times. 
Physical examination revealed erythematous to 
violaceous, non-blanchable papules and plaques 
with some yellow, atrophic patches and overlying 
scattered black, crusted nodules on the left distal 
lower extremity with mild edematous changes noted 
in the lower extremities (Figure 1). The patient 
denied any history of prior radiation to the area. 
Two 5mm punch biopsies were performed on the left 
distal and proximal lower leg. The upper dermis 
showed thin walled vessels with irregularly shaped  
Abstract 
Angiosarcomas are malignant neoplasms arising 
from endothelial cells. Cutaneous angiosarcoma is 
the most common form, typically occurring in the 
setting of chronic lymphedema or previous radiation. 
The head and neck are the most common locations 
for cutaneous angiosarcoma, with rare occurrence on 
the trunk and extremities. Herein, we present a case 
of angiosarcoma on the lower extremity in an elderly 
man. This 71-year-old man presented with a two-year 
history of red-yellow discoloration of the left lower 
leg with subsequent development of black nodules 
over the past several months prior to presentation. 
He denied any itching, bleeding, or ulceration. Past 
medical history included diabetes, hypertension, and 
non-melanoma skin cancer. Physical examination 
showed erythematous, violaceous, non-blanchable 
papules with yellow atrophic regions and overlying 
black crusted nodules and plaques. Biopsies were 
taken and the patient was diagnosed with 
angiosarcoma and referred to a tertiary care center 
for further evaluation. 
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jagged lumen lined with endothelial cells with 
protuberant hyperchromatic nuclei and papillations 
extending into some lumen (Figure 2). CD31 (Figure 
3) and CD34 (Figure 4) stains were positive, 
indicating a vascular origin of the tumor. Staining for 
HHV8 (Figure 5) was negative, effectively excluding 
Kaposi sarcoma from the differential diagnosis. The 
initial diagnosis was an atypical vascular 
proliferation, with a differential diagnosis of diffuse 
dermal angiomatosis, which would also stain 
positively for CD31 and CD34 [4]. Further staining 
revealed D240+, which suggested a partially 
lymphatic endothelial immunophenotype with a 
degree of nuclear enlargement and hyperchromasia. 
These findings, along with the irregular nuclei and 
jagged vessel lumen described above, were 
consistent with angiosarcoma. 
The patient was subsequently referred to a tertiary 
care center for further evaluation and management. 
The patient underwent 21×20cm wide local excision 
of the left leg, which revealed close peripheral 
margins and involved deep margin. He was 
subsequently referred for postoperative external 
beam radiotherapy over a 6-7-week period (6600cGy 
in 33 fractions). The patient declined radiotherapy 
treatment at that time and was subsequently lost to 
follow-up. 
 
Case Discussion 
Angiosarcoma is a rare malignant neoplasm of 
endothelial origin [3]. It is classified into 5 main types:  
cutaneous angiosarcoma, soft tissue angiosarcoma, 
primary-breast angiosarcoma, lymphedema-
associated angiosarcoma, and radiation-induced 
angiosarcoma [1]. Stewart-Treves syndrome 
describes the most common type of angiosarcoma in 
the setting of chronic lymphedema, usually 
appearing on the upper extremity after mastectomy 
with lymph node dissection [3, 5]. 
 
Figure 1. Large violaceous plaques with overlying dark crusted 
nodules on the left pretibial region. 
Figure 2. Thin walled vessels in the upper dermis with irregularly 
shaped jagged lumen. A) H&E, 20×, B) H&E, 40×. C) Endothelial 
cells with prominent and hyperchromatic nuclei. H&E, 200×. 
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Cutaneous angiosarcoma is the most common 
subtype, comprising about 60% of all 
angiosarcomas; about 50% appear in the head and 
neck [2]. Cutaneous angiosarcoma affects men 
slightly more often than women. Typically, older 
patients are more commonly diagnosed, with the 
highest incidence seen in those older than 70 years 
[3, 6, 7]. 
Angiosarcoma lesions typically present as a dark 
patch resembling a bruise. As the tumor progresses, 
violaceous nodules develop that tend to bleed easily 
with risk of ulceration. In the setting of lymphedema, 
indurated plaques or firm nodules appear on 
underlying non-pitting edema [3]. Differential 
diagnoses should include other types of vascular 
tumors, including but not limited to, capillary  
hemangiomas, Kaposi sarcoma, epithelioid 
hemangioendotheliomas, and hemangiopericytomas 
[1]. These can be differentiated with appropriate 
clinical context and history as well as histopathologic 
evaluation. 
On histologic examination, the malignant 
endothelial cells of angiosarcoma can take on a 
rounded, polygonal or fusiform shape [1]. In well-
differentiated cutaneous angiosarcomas, flattened 
endothelial cells line vascular channels arranged in 
an irregular anastomosing pattern creating splits 
between the collagen bundles [2, 3]. In moderately 
differentiated angiosarcomas, the vascular channels 
are more densely packed with multiple layers of 
endothelial cells that exhibit increased nuclear 
pleomorphism and formation of intraluminal 
papillae [2, 3]. Poorly differentiated angiosarcomas 
are less often cutaneous and will often have similar 
characteristics to other sarcomas or carcinomas, 
including endothelial cells with an epithelioid 
appearance forming sheets and necrotic and 
hemorrhagic areas [1, 2]. 
Treatment includes surgical excision with wide 
margins, chemotherapy, and radiation therapy [3]. 
Surgical excision is the primary treatment of choice, 
followed by radiation, as excision with negative 
margins is difficult to achieve owing to the invasive 
nature of angiosarcoma in addition to the increased 
likelihood of recurrence [1]. Chemotherapy is usually 
the treatment of choice for metastatic angiosarcoma 
Figure 3. Positive CD31 stain. 
Figure 5. Negative HHV8 stain. 
Figure 4. Positive CD34 stain. 
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[1]. Doxorubicin, paclitaxel, and docetaxel have been 
cited as chemotherapeutic options in previous 
studies [8]. 
The prognosis of angiosarcoma is historically quite 
poor, with a 5-year survival at less than 15% [3]. Other 
studies found 5-year survival rates slightly higher, at 
around 20% or 34% [6, 10]. Albores-Saavedra et al. 
found that cutaneous angiosarcomas of the lower 
extremities had a 5-year survival of 64% [6]. Morgan 
et al. found that characteristics associated with the 
worst outcomes are tumor diameter greater than 
5cm, depth of invasion greater than 3mm, positive 
margins, recurrence, and metastasis [9]. 
Our case is an unusual presentation of cutaneous 
angiosarcoma because it occurred on the lower leg. 
His initial diagnosis of necrobiosis lipoidica based on 
clinical appearance is somewhat unsurprising given 
its common appearance on the pretibial surface of 
the lower extremity (although usually bilaterally), as 
well as its typical morphology of well-demarcated 
yellow-brown plaques with violaceous borders and 
central areas of atrophic change [10]. Deyrup et al. 
reviewed studies of sporadic cutaneous 
angiosarcomas and commented that those 
occurring on the trunk or extremities carry a worse 
prognosis than those of the head or neck, noting that 
angiosarcomas of the trunk or extremities displayed  
higher risk histologic features associated with worse 
prognosis [11]. A 2013 case report discussed a 
patient with a poorly differentiated cutaneous 
angiosarcoma of the leg with no history of 
lymphedema or radiotherapy who ultimately 
received an above the knee amputation and 
remained free of recurrence or metastasis eleven 
months after surgery [12]. There are other case 
reports describing cutaneous angiosarcoma arising 
in the lower extremity, mainly citing a history of 
chronic lymphedema in the affected extremity [13, 
14]. 
 
Conclusion 
Angiosarcoma is a rare malignancy and carries a very 
poor prognosis. It occurs spontaneously or in the 
setting of chronic lymphedema or previous radiation 
therapy. Cutaneous angiosarcoma mainly occurs on 
the face, neck, or scalp and less commonly on the 
trunk or extremities. Timely recognition of 
angiosarcoma is important so that the patient can be 
referred for surgical excision and any necessary 
adjuvant treatment in order to optimize survival. 
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